New Co-Editor-in-Chief Appointed Lorraine V. Kalia, MD, PhD, FRCPC, an Associate Professor and Clinician Scientist in the Division of Neurology at the University of Toronto and a Senior Scientist at the Krembil Research Institute of the University Health Network, joins JPD! Click for details.
New Blog Written by Sharon Krischer Going to the World Parkinson Congress for the first time can be an exciting challenge for a person with Parkinson’s disease. On the one hand, there is so much to see and do it is almost like a Disneyland for People with Parkinson’s. On the other hand, how do you fit everything into 3,5 days? Somehow, executive director Elizabeth (Eli) Pollard and her team managed to bring together an amazing international conference that is inspiring, educational and welcoming to all in the Parkinson’s community.
New Blog Written by Frank C. Church, PhD Cure Parkinson's (CP) started the international Linked Clinical Trials (iLCT) initiative to repurpose drugs for the treatment of Parkinson's disease (PD). Combining priorities with the Van Andel Institute (VAI), they hold an annual two-day meeting to present, examine, discuss, and prioritize suitable compounds for streamlining into clinical trials specifically for slowing down/stopping/reversing the progression of PD.
Watch the latest recording of our Quarterly Parkinson's Webinars by clicking above or here, and discover all about the webinar series & watch all recordings here!